NexImmune, Inc. (NEXI)
OTCMKTS
· Delayed Price · Currency is USD
0.253
-0.071 (-21.91%)
Nov 15, 2024, 4:00 PM EST
NexImmune Market Cap
NexImmune has a market cap or net worth of $352.85 thousand as of November 15, 2024. Its market cap has decreased by -91.81% in one year.
Market Cap
352.85K
Enterprise Value
-2.07M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.25
Market Cap Chart
Since February 12, 2021, NexImmune's market cap has decreased from 545.88M to 352.85K, a decrease of -99.94%. That is a compound annual growth rate of -85.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2024 | 451.18K | -80.79% |
| Dec 29, 2023 | 2.35M | -62.95% |
| Dec 30, 2022 | 6.34M | -93.94% |
| Dec 31, 2021 | 104.70M | -80.82% |
| Feb 12, 2021 | 545.88M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sandoz Group AG | 19.44B |
| Telix Pharmaceuticals Limited | 4.95B |
| Elekta AB (publ) | 2.22B |
| Ryman Healthcare Limited | 1.93B |
| Verano Holdings Corp. | 600.94M |
| Vireo Growth Inc. | 110.67M |
| Medexus Pharmaceuticals Inc. | 37.13M |